Schizophrenia Mortality: Barriers to Progress

  title={Schizophrenia Mortality: Barriers to Progress},
  author={Mary V. Seeman},
  journal={Psychiatric Quarterly},
  • M. Seeman
  • Published 30 May 2019
  • Medicine, Psychology
  • Psychiatric Quarterly
Individuals with schizophrenia die, on average, 20 years before their peers, with ‘natural causes’ accounting for 80% of premature deaths. The aim of this narrative review is to address this phenomenon from the perspective of known factors that contribute to long life. The relevant literature from the last decade was searched in PubMed and Google Scholar databases. Four factors have been shown to be common to centarians, people who live to be a hundred: genes, life style behaviors that favor a… 
Schizophrenia and cancer.
The literature makes recommendations about surmounting barriers and also offers suggestions with respect to support and palliative care in advanced stages of cancer, including examples of effective collaboration between mental health and cancer care specialists.
Women with Schizophrenia over the Life Span: Health Promotion, Treatment and Outcomes
A narrative review of treatment of women with schizophrenia at different periods of their life paying special attention to reproductive and post-reproductive stages suggests that menstrual cycle-dependent treatments may be a useful option for many women and that recommendations re contraceptive options need always to be part of care provision.
Natural cause mortality of mental health consumers: A 10-year retrospective cohort study.
There is a critical need to close the life expectancy gap for consumers with mental illness through dedicated focus on reducing mortality risk due to modifiable clinical characteristics which lead to consumer mortality.
Social Processes Associated With Health and Health Behaviors Linked to Early Mortality in People With a Diagnosis of a Serious Mental Illness
This paradigm explores how loneliness, stigma (social and self), trauma, trauma, social exclusion, social isolation, and social isolation are related to early mortality in people with SMI.
Treatment patterns and appropriateness of antipsychotic prescriptions in patients with schizophrenia
Overall, a high level of inappropriateness in antipsychotic prescriptions was observed, and greater adherence to guidelines could maximize the benefits of antipsychotics medications while minimizing risk of adverse effects.
Gut microbiota and microbiome in schizophrenia
A narrative review of studies addressing gut microbiota alterations in patients with schizophrenia that were published in the years 2019–2020 finds that findings from clinical trials do not support the use of probiotics as add-on treatments in schizophrenia.
Communication strategies for nursing research with older adults diagnosed with schizophrenia using life course theory.
  • V. Walker
  • Medicine
    Journal of nursing scholarship : an official publication of Sigma Theta Tau International Honor Society of Nursing
  • 2021
The strategies delineated in this paper are part of an ongoing project to co-develop a model with older adults diagnosed with schizophrenia specifically tailored to improve their health outcomes and quality of life.
Synonymous polymorphism rs201256011 in dopamine receptor type 2 gene is associated with schizophrenia and PANSS score in Pakistani population: A first report
Keeping in view the genetic diversity among populations and important role of DRD2 polymorphisms in schizophrenia, two of its SNPs rs1801028 and rs6277 in patients with schizophrenia from Pakistan were studied.


Trends in mortality in schizophrenia and their implications
A striking finding from this new Finnish study is the marked reduction in the proportion of patients with schizophrenia followed up over years with follow-up mortality data, which appears to indicate that the mortality gap is not widening in schizophrenia in some settings.
Twenty-five year mortality of a community cohort with schizophrenia
People with schizophrenia have a mortality risk that is two to three times that of the general population, and most of the extra deaths are from natural causes.
Mortality in people with psychotic disorders in Finland: A population-based 13-year follow-up study
The dietary pattern of patients with schizophrenia: a systematic review.
Existential questions in schizophrenia: perception of patients and caregivers.
To develop a new type of health care in which both the consideration for the person with schizophrenia and their subjectivity are as important as biological treatment, health promotion strategies need to combat stigma and use mechanisms of occupational inclusion.
Mortality in mental disorders: Are we approaching to close the gap respect to other medical specialties? The case of schizophrenia
Only the implementation of accurate clinical monitoring and a stronger engagement of the medical field in the care of people affected by mental disorders, will overcome the scandal of the underestimation of their physical health problems.
Cardiometabolic health, prescribed antipsychotics and health-related quality of life in people with schizophrenia-spectrum disorders: a cross-sectional study
The findings indicate that cardiometabolic health risks in people with SSD may be more common than those reported in the general Hong Kong population and provide further support for the need to consider antipsychotic polypharmacy and higher doses of antipsychotics as factors that may contribute towards cardiometric risk in Chinese patients with SSD.
Solitude and schizophrenia
Abstract Purpose: The aim of this review is to better understand the motives of individuals diagnosed with clinical schizophrenia who indicate that they want time alone. Is wanting solitude best
Treating the “E” in “G × E”: Trauma-Informed Approaches and Psychological Therapy Interventions in Psychosis
The recent advances elucidating the complex genetic architecture of schizophrenia, as well as the long-term effects of early life trauma on brain function and future mental health risk, are covered.